# A Phase I/II Clinical Trial of PepCan in Head and Neck Cancer Patients

> **NCT03821272** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Arkansas** · enrollment: 17 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **BIOLOGICAL:** PepCan
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT03821272
- **Lead sponsor:** University of Arkansas
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-13
- **Primary completion:** 2025-02-03
- **Final completion:** 2025-02-03
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2025-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03821272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03821272, "A Phase I/II Clinical Trial of PepCan in Head and Neck Cancer Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03821272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*